文献速递细胞病理与分子病理

快速现场评估对甲状腺细针穿刺活检的影响:两年癌症中心机构经验

The impact of rapid on-site evaluation on thyroid fine-needle aspiration biopsy: A 2-year cancer center institutional experience.
PubMed 文献 · Cancer Cytopathol · 2018-10-14

该研究回顾性分析2015年7月至2017年7月间4649例超声引导下甲状腺细针穿刺活检,其中3469例(74.6%)行快速现场评估(ROSE),1180例(25.4%)未行ROSE。结果显示ROSE组标本充足率显著更高(93.4% vs 69.4%,P<.0001),达到充足诊断所需平均穿刺次数为1.48±0.71次,且两组各TBSRTC分类的风险恶性肿瘤(ROM)无统计学差异。结论支持ROSE在甲状腺FNAB中可提高标本充足率并减少穿刺次数,且不影响ROM。

要点

  • ROSE组标本充足率93.4%,显著高于非ROSE组的69.4%(P<.0001)。
  • ROSE组达到充足诊断平均需1.48±0.71次穿刺(中位1次,范围1-5次)。
  • 两组各TBSRTC分类的ROM无统计学差异。

核心结论

  • ROSE是甲状腺FNAB中有价值的技术,可显著提高标本充足率并减少达到充足诊断所需的平均穿刺次数,且不影响各TBSRTC分类的ROM。

研究设计与样本

  • 回顾性纳入2015年7月至2017年7月所有超声引导下甲状腺FNAB,共4649例细胞学标本,ROSE组3469例(74.6%),非ROSE组1180例(25.4%)。
  • ROSE由经验丰富的细胞病理学家进行,采用Romanowsky染色玻片即时评估;非ROSE时默认行3次穿刺。
  • 采用卡方检验比较两组标本充足率及各TBSRTC分类的ROM。

主要发现

  • 患者以女性为主(85.4%),平均年龄53岁。
  • ROSE组标本充足率93.4%,非ROSE组69.4%,差异有统计学意义(P<.0001)。
  • ROSE组达到充足诊断的平均穿刺次数为1.48±0.71次(中位1.0次,范围1-5次)。
  • 两组各TBSRTC分类的ROM比较无统计学差异。

关键数值与推荐

  • 标本充足率:ROSE组93.4% vs 非ROSE组69.4%(P<.0001)。
  • ROSE组平均穿刺次数1.48±0.71次(中位1.0次,范围1-5次)。

临床怎么用

  • 在甲状腺FNAB中实施ROSE可提高标本充足率并减少穿刺次数,且不改变各TBSRTC分类的ROM。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of rapid on-site evaluation (ROSE) on thyroid aspirates has been a matter of extensive debate. In the current study, the authors reviewed all thyroid fine-needle aspiration biopsies (FNABs) performed in their service in recent years to evaluate the impact of ROSE on final adequacy and diagnostic rates. METHODS: All ultrasound-guided FNABs of the thyroid performed between July 2015 and July 2017 were included retrospectively. ROSE was performed by experienced cytopathologists, with production of Romanowsky-stained slides for immediate evaluation. When ROSE was not performed, a total of 3 needle passes were performed as the default. Final specimen adequacy and the risk of malignancy (ROM) of each The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) category were calculated in the 2 groups (ROSE and non-ROSE) and compared using the chi-square test. RESULTS: An initial search obtained 4649 cytology specimens, 3469 of which (74.6%) underwent ROSE and 1180 of which (25.4%) did not. Patients were predominantly female (85.4%), with a mean age of 53 years. Specimen adequacy was found to be significantly higher in the ROSE group (93.4% vs 69.4%; P<.0001), with a mean number of needle passes necessary for an adequate diagnosis of 1.48 ± 0.71 (median, 1.0 needle passes; range, 1-5 needle passes). No statistical difference was observed with regard to the ROM for each TBSRTC category when the 2 groups (ROSE and non-ROSE) were compared. CONCLUSIONS: The current study data support ROSE as a valuable technique in thyroid FNAB. It was proven to significantly improve specimen adequacy with a decreased mean number of needle passes necessary to achieve an adequate cytological diagnosis and no impact on the ROM for any TBSRTC category.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Pastorello RG, Destefani C, Pinto PH, et al. The impact of rapid on-site evaluation on thyroid fine-needle aspiration biopsy: A 2-year cancer center institutional experience. Cancer Cytopathol. 2018. PMID: 30317695. doi:10.1002/cncy.22051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。